# US 2012/0252755 A1 · Compositions and methods for disinfecting materials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252755 A1
- Document ID: US20120252755A1
- Status: Published application
- Kind: A1
- Application number: 13/393,520
- Filed: 2010-09-01
- Published: 2012-10-04
- Earliest claimed: 2009-09-04
- Assignees: Medoderm GmbH
- Inventors: Karsten Henco; Thomas Freier; Rivelino Montenegro
- Web page: https://patentgrep.com/patent/US20120252755A1

## CPC

- A61L 26/0023: {Polysaccharides}
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 26/0066: {Medicaments; Biocides}
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/02: Local antiseptics
- A61P 31/04: Antibacterial agents
- A61P 31/06: for tuberculosis
- A61P 31/10: Antimycotics
- A61P 31/12: Antivirals
- A61L 2300/232: Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention relates to methods for disinfecting or decontaminating a material or for preventing an infection or contamination of a material. The invention further relates to compositions which are suitable for disinfecting a material or for preventing an infection or contamination of a material and to uses of such compositions. The invention further relates to a medical use of chitosan and to a pharmaceutical composition comprising the chitosan. The invention further relates to a method of treating a microbial infection and to an aqueous solution comprising chitosan. The invention moreover relates to a chitosan or a pharmaceutical composition comprising a chitosan for an epithelial cell growth stimulating treatment of a patient's tissue and to a method of stimulating the growth of epithelial cells. The invention also relates to a tissue dressing material.

## Claims

### Claim at position 1

1-55. (canceled)

### Claim 56

A composition for treating a material, wherein the composition comprises a chitosan having a first fraction and a second fraction, wherein the first fraction of the chitosan forms a deposit on a surface of the material and/or is insoluble in the material and the second fraction of the chitosan penetrates into and/or is soluble in the material.

### Claim 57 (depends on 56)

The composition of claim 56, wherein the material is a hydrophilic material, and wherein optionally the material is an aqueous solution or an aqueous suspension.

### Claim 58 (depends on 56)

The composition of claim 56, wherein the second fraction of chitosan has a concentration in an interface region of the material in a range of from about 0.01% w/v to about 1.0% w/v, and optionally from about 0.1% w/v to about 0.9% w/v, wherein optionally the interface region of the material has a depth of 5 mm or less, optionally a depth of 2 mm or less.

### Claim 59 (depends on 56)

The composition of claim 56, wherein the composition is an aqueous solution, wherein optionally the aqueous solution does not contain an organic solubilizer and/or wherein optionally the aqueous solution does not contain an alcohol and/or wherein optionally the solution has a pH of 5 to 6, optionally a pH of about 5.5.

### Claim 60 (depends on 56)

The composition of claim 56, wherein the chitosan is native chitosan.

### Claim 61 (depends on 56)

The composition of claim 56, wherein the chitosan has a degree of acetylation of 40% or less, optionally of 2% or less and optionally of 1.5% or less.

### Claim 62 (depends on 56)

The composition of claim 56, wherein the first fraction comprises more than 10% of the total content of chitosan in the composition and/or wherein the first fraction is in a form that is insoluble at a pH of 6.5 or greater and/or wherein the second fraction comprises more than 1% of the total content of chitosan in the composition and/or wherein the second fraction is present in a form that is soluble at a pH of 6.5 to 8 and/or wherein the first fraction of the chitosan contains polymers having a molecular weight of 10 kD or more and/or wherein the second fraction of the chitosan contains oligomers or low-molecular weight polymers having a molecular weight of less than 10 kD.

### Claim 63 (depends on 56)

The composition of claim 56, wherein the first fraction of the chitosan forms a solid or gel-like precipitate on the surface of the material or in the material.

### Claim 64 (depends on 56)

The composition of claim 56, wherein the composition is aerosolizable, suspensable, sprayable and/or inhalable.

### Claim 65

A method of disinfecting a material or preventing an infection or contamination of a material comprising the following steps:
a) providing a composition having a concentration of a chitosan which is equal to or lower than an effective concentration for disinfecting the material or preventing an infection or contamination of the material;
b) contacting the composition with the material.

### Claim 66 (depends on 65)

The method of claim 65, wherein the infection or contamination is a bacterial, fungal or viral infection or contamination and optionally an infection or contamination with multi resistant S. aureus, E. coli, P. aeruginosa and/or B. tuberculosis.

### Claim 67 (depends on 65)

The method of claim 65, further comprising:
c) forming a deposit of a first fraction of the chitosan on a surface of the material or forming a deposit of a first fraction of the chitosan in the material, wherein optionally the deposit is a solid or gel-like precipitate and/or wherein optionally step c) further comprises evaporating a solvent contained in the deposit.

### Claim 68 (depends on 65)

The method of claim 65, further comprising:
d) transporting a second fraction of the chitosan into the material, or dissolving a second fraction of the chitosan in the material.

### Claim 69 (depends on 65)

The method of claim 65, wherein the material is a human or animal tissue, wherein optionally the tissue is a healthy tissue, alveole, wound, burn, abrasion, perforation, cut or laceration, or wherein the material is an aqueous suspension or an aqueous suspension, or wherein the material is an inanimate material, which is optionally selected from the group consisting of a clothing, a wallpaper, a medical gown, a medical facecover, a hydrophilic surface in a medical suite, and medical equipment.

### Claim 70 (depends on 65)

The method of claim 65, wherein the composition is administered topically and/or wherein the composition is applied drop-wise or by aerolizing, suspending or spraying.

### Claim 71 (depends on 65)

The method of claim 65, wherein the composition has a concentration of the chitosan from about 0.05% w/v to about 5.0% w/v, optionally from about 0.75% w/v to about 1.0% w/v.

### Claim 72 (depends on 65)

The method of claim 65, wherein the composition is an aqueous solution, wherein optionally the aqueous solution does not contain an organic solubilizer such as an alcohol and/or wherein optionally the aqueous solution does not contain an alcohol and/or wherein optionally the solution has a pH of 5 to 6, and optionally a pH of about 5.5.

### Claim 73 (depends on 65)

The method of claim 65, wherein the chitosan is native chitosan.

### Claim 74 (depends on 65)

The method of claim 65, wherein the chitosan has a degree of acetylation of 40% or less, optionally of 2% or less and, optionally, of 1.5% or less.

### Claim 75 (depends on 65)

The method of claim 65, wherein the first fraction comprises more than 10% of the total content of chitosan in the composition and/or wherein the first fraction is in a form that is insoluble at a pH of 6.5 or greater and/or wherein the second fraction comprises more than 1% of the total content of chitosan in the composition and/or wherein the second fraction is present in a form that is soluble at a pH of 6.5 to 8 and/or wherein the first fraction of the chitosan contains polymers having a molecular weight of 10 kD or more and/or wherein the second fraction of the chitosan contains oligomers or low-molecular weight polymers having a molecular weight of less than 10 kD.

### Claim 76 (depends on 56)

A pharmaceutical composition comprising the composition of claim 56.

### Claim 77 (depends on 56)

A method of treating wounds, repairing wounds, tissue remodeling of wounds, disinfecting wounds, promoting hemostasis, preventing or treating microbial infections, or simultaneous promoting hemostasis, disinfecting wounds and repairing the tissue of wounds, in a human or animal, the method comprising:
identifying a human or animal in need thereof, and
administering to the human or animal a composition of claim 56.

### Claim 78 (depends on 56)

A method of disinfecting of solutions selected from the group consisting of an infusion solution, a nutrition solution and a neutraceutical solution, or for disinfecting or preventing a microbial infection of drinking water for human or animal use, the method comprising contacting the solution or drinking water with a composition of claim 56.
